Pituitary action of cytokines: Focus on BMP-4 and gp130 family

The anterior pituitary can develop benign tumors of different sizes, classified as micro- and macroadenomas, frequently associated with high levels of hormone production, leading to different associated syndromes like Cushing's disease, acromegaly or prolactinomas. Much work has been done in or...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Giacomini, D.
Otros Autores: Acuña, M., Gerez, J., Nagashima, A.C, Silberstein, S., Páez-Pereda, M., Labeur, M., Theodoropoulou, M., Renner, U., Stalla, G.K, Arzt, E.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2007
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
Descripción
Sumario:The anterior pituitary can develop benign tumors of different sizes, classified as micro- and macroadenomas, frequently associated with high levels of hormone production, leading to different associated syndromes like Cushing's disease, acromegaly or prolactinomas. Much work has been done in order to understand the signaling pathways and the factors and hormones involved in the pituitary tumorigenic process. In recent years, much evidence has been collected and it is now well documented that cytokines of the gp130 family, such as interleukin-6, that use gp130 as a common signaling protein stimulate not only the proliferation but also the hormone secretion of pituitary cells. Experiments in vivo have shown that the overexpression of the gp130 receptor resulted in pituitary abnormal growth. Moreover, it has been recently described that bone morphogenetic protein-4 (BMP-4), a member of the TGF-β family, has a stimulatory role on lactosomatotropic cells promoting the development of prolactinomas but it has an inhibitory action on the corticotropic lineage. This inhibitory action prevents Cushing's disease progression. Furthermore, BMP-4 mediates the antiproliferative action of retinoic acid in these cells. The present review highlights the most recent work about gp130 and TGF-β cytokine families and their role in pituitary tumorigenesis. Copyright © 2007 S. Karger AG.
Bibliografía:Asa, S.L., Ezzat, S., The pathogenesis of pituitary tumours (2002) Nat Rev Cancer, 2, pp. 836-849
Kovacs, K., Horvath, E., Vidal, S., Classification of pituitary adenomas (2001) J Neurooncol, 54, pp. 121-127
Yu, R., Melmed, S., Oncogene activation in pituitary tumors (2001) Brain Pathol, 11, pp. 328-341
Arzt, E., Pereda, M.P., Castro, C.P., Pagotto, U., Renner, U., Stalla, G.K., Pathophysiological role of the cytokine network in the anterior pituitary gland (1999) Front Neuroendocrinol, 20, pp. 71-95
Arzt, E., gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuroendocrine pathways (2001) J Clin Invest, 108, pp. 1729-1733
Hirano, T., Interleukin-6 (1994) The Cytokine Handbook, pp. 145-168. , Thomson AW ed, ed 2. Osaka, Academic Press
Kishimoto, T., Taga, T., Akira, S., Cytokine signal transduction (1994) Cell, 76, pp. 253-262
Kishimoto, T., Akira, S., Narazaki, M., Taga, T., Interleukin-6 family of cytokines and gp130 (1995) Blood, 86, pp. 1243-1254
Heinrich, P.C., Behrmann, I., Muller-Newen, G., Schaper, F., Graeve, L., Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway (1998) Biochem J, 334, pp. 297-314
Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Kishimoto, T., Targeted disruption of gp130, a common signal transducer for the interleukin-6 family, leads to myocardial and hematological disorders (1996) Proc Natl Acad Sci USA, 93, pp. 407-411
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., Akira, S., Targeted disruption of the mouse Stat3 gene leads to early embryonic lathality (1997) Proc Natl Acad Sci USA, 94, pp. 3801-3804
Rodig, S.J., Meraz, M.A., White, J.M., Lampe, P.A., Riley, J.K., Arthur, C.D., Kind, K.L., Schreiber, R.D., Disruption of the JaK1 gene demonstrates obligatory and nonredundant roles of the JaKs in cytokine-induced biologic responses (1998) Cell, 93, pp. 373-383
Betz, U.A., Bloch, W., van den Broek, M., Yoshida, K., Taga, T., Kishimoto, T., Addicks, K., Muller, W., Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects (1998) J Exp Med, 188, pp. 1955-1965
Massague, J., How cells read TGF-β signals (2000) Nat Rev Mol Cell Biol, 1, pp. 169-178
Massague, J., TGF-β signal transduction (1998) Annu Rev Biochem, 67, pp. 753-791
Shi, Y., Massague, J., Mechanisms of TGF-β signaling from cell membrane to the nucleus (2003) Cell, 113, pp. 685-700
Spangelo, B.L., MacLeod, R.M., Isakson, P.C., Production of interleukin-6 by anterior pituitary cells in vitro (1990) Endocrinology, 126, pp. 582-586
Vankelecom, H., Carmeliet, P., Van Damme, J., Billiau, A., Denef, C., Production of interleukin-6 by folliculostellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system (1989) Neuroendocrinology, 49, pp. 102-106
Ray, D., Melmed, S., Pituitary cytokine and growth factor expression and action (1997) Endocr Rev, 18, pp. 206-228
Arzt, E., Páez Pereda, M., Costas, M., Sauer, J., Renner, U., Holsboer, F., Stalla, G.K., Cytokine expression and molecular mechanisms of their auto/paracrine regulation of anterior pituitary function and growth (1998) Ann NY Acad Sci, 840, pp. 525-531
Renner, U., Gloddek, J., Páez Pereda, M., Arzt, E., Stalla, G.K., Regulation and role of intrapituitary IL-6 production by folliculostellate cells (1998) Domest Anim Endocrinol, 15, pp. 353-362
Arzt, E., Páez Pereda, M., Perez Castro, C., Kovalovsky, D., Nagashima, A.C., Renner, U., Stalla, G.K., Cytokines and pituitary function (1999) Regulation in Pituitary Hormone Secretion, pp. 15-26. , Beck-Peccoz P ed, BioScientifica Ltd. Bristol, UK
Spangelo, B.L., Gorospe, W.C., Role of the cytokines in the neuroendocrine-immune system axis (1995) Front Neuroendocrinol, 16, pp. 1-12
Páez Pereda, M., Lohrer, P., Kovalovsky, D., Perez Castro, C., Goldberg, V., Losa, M., Chervín, A., Arzt, E., Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas (2000) Exp Clin Endocrinol Diabetes, 108, pp. 202-207
Scully, K.M., Rosenfeld, M.G., Pituitary development: Regulatory codes in mammalian organogenesis (2002) Science, 295, pp. 2231-2235
Treier, M., Gleiberman, A.S., O'Connell, S.M., Szeto, D.P., McMahon, J.A., McMahon, A.P., Rosenfeld, M.G., Multistep signaling requirements for pituitary organogenesis in vivo (1998) Genes Dev, 12, pp. 1691-1704
Drouin, J., Molecular mechanisms of pituitary differentiation and regulation: Implications for hormone deficiencies and hormone resistance syndromes (2006) Front Horm Res, 35, pp. 74-87
Dasen, J.S., Rosenfeld, M.G., Signaling and transcriptional mechanisms in pituitary development (2001) Annu Rev Neurosci, 24, pp. 327-355
Ericson, J., Norlin, S., Jessell, T.M., Edlund, T., Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary (1998) Development, 125, pp. 1005-1015
Watkins-Chow, D.E., Camper, S.A., How many homeobox genes does it take to make a pituitary gland? (1998) Trends Genet, 14, pp. 284-290
Páez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A.C., Hopfner, U., Grubler, Y., Chervin, A., Arzt, E., Involvement of bone morphogenetic protein-4 in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk (2003) Proc Natl Acad Sci USA, 100, pp. 1034-1039
Giacomini, D., Páez-Pereda, M., Theodoropoulou, M., Labeur, M., Refojo, D., Gerez, J., Chervin, A., Arzt, E., Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action (2006) Endocrinology, 147, pp. 247-256
Takeda, M., Otsuka, F., Suzuki, J., Kishida, M., Ogura, T., Tamiya, T., Makino, H., Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas (2003) Biochem Biophys Res Commun, 306, pp. 812-818
Lyson, K., McCann, S.M., The effect of interleukin-6 on pituitary hormone release in vivo and in vitro (1991) Neuroendocrinology, 54, pp. 262-266
Arzt, E., Buric, R., Stelzer, G., Stalla, J., Sauer, J., Renner, U., Stalla, G.K., Interleukin (IL) involvement in anterior pituitary cell growth regulation: Effects of IL-2 and IL-6 (1993) Endocrinology, 132, pp. 459-467
Renner, U., Gloddek, J., Arzt, E., Inoue, K., Stalla, G.K., Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells (1997) Exp Clin Endocrinol Diabetes, 105, pp. 345-352
Sawada, T., Koike, K., Kanda, Y., Ikegami, H., Jikihara, T., Maeda, T., Osako, Y., Miyake, A., Interleukin-6 stimulates cell proliferation of rat anterior pituitary clonal cell lines in vitro (1995) J Endocrinol Invest, 18, pp. 83-90
Páez Pereda, M., Goldberg, V., Chervin, A., Carrizo, G., Molina, A., Andrada, J., Sauer, J., Arzt, E., Interleukin (IL)-2 and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants (1996) Mol Cell Endocrinol, 124, pp. 33-42
Perez Castro, C., Nagashima, A.C., Pereda, M.P., Goldberg, V., Chervin, A., Largen, P., Renner, U., Arzt, E., The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the function and growth of lactosomatotropic and folliculostellate pituitary cell lines (2000) Endocrinology, 141, pp. 1746-1753
Nudi, M., Ouimette, J.F., Drouin, J., Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity (2005) Mol Endocrinol, 19, pp. 1329-1342
Páez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Stalla, G., Retinoic acid prevents experimental Cushing syndrome (2001) J Clin Invest, 108, pp. 1123-1131
Castillo, V., Giacomini, D., Páez-Pereda, M., Stalla, J., Labeur, M., Theodoropoulou, M., Holsboer, F., Arzt, E., Retinoic acid as a novel medical therapy for Cushing's disease in dogs (2006) Endocrinology, 147, pp. 4438-4444
Horiguchi, A., Oya, M., Marumo, K., Murai, M., STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P (2002) Kidney Int, 61, pp. 926-938
Liu, X.H., Kirschenbaum, A., Lu, M., Yao, S., Klausner, A., Preston, C., Holland, J.F., Levine, A.C., Prostaglandin E2 stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway (2002) Biochem Biophys Res Commun, 290, pp. 249-255
Campbell, C.L., Jiang, Z., Savarese, D.M., Savarese, T.M., Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma (2001) Am J Pathol, 158, pp. 25-32
Burger, R., Guenther, A., Bakker, F., Schmalzing, M., Bernand, S., Baum, W., Duerr, B., Gramatzki, M., gp130 and ras mediated signaling in human plasma cell line INA-6: A cytokine-regulated tumor model for plasmacytoma (2001) Hematol J, 2, pp. 42-53
Leung, C.K.H., Shiu, P.C., Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice (1981) Cancer Res, 41, pp. 546-551
Yano, T., Uozumi, T., Kawamoto, K., Mukada, K., Onda, J., Ito, A., Fujimoto, N., Photodynamic therapy for rat pituitary tumor in vitro and in vivo using pheophorbide-a and white light (1991) Lasers Surg Med, 11, pp. 174-182
Davalli, A.M., Galbiati, F., Bertuzzi, F., Polastri, L., Pontiroli, A.E., Perego, L., Freschi, M., Meoni, C., Insulin-secreting pituitary GH3 cells: A potential β-cell surrogate for diabetes cell therapy (2000) Cell Transplant, 9, pp. 841-851
Castro, C.P., Giacomini, D., Nagashima, A.C., Onofri, C., Graciarena, M., Kobayashi, K., Páez-Pereda, M., Arzt, E., Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells (2003) Endocrinology, 144, pp. 693-700
Tone, E., Kunisawa, K., Kumanogoh, A., Negoro, S., Funamoto, M., Osugi, T., Kishimoto, T., Yamauchi-Takihara, K., gp130-dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation (2000) Cytokine, 12, pp. 1512-1518
Koyama, C., Matsumoto, H., Sakai, T., Wakabayashi, K., Ito, A., Couch, E.F., Inoue, K., Pituitary folliculo-stellate-like cells stimulate somatotropic pituitary tumor growth in nude mice (1995) Endocr Pathol, 6, pp. 67-75
Graciarena, M., Carbia-Nagashima, A., Onofri, C., Perez-Castro, C., Giacomini, D., Renner, U., Stalla, G.K., Arzt, E., Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model (2004) Eur J Endocrinol, 151, pp. 595-604
ISSN:00283835
DOI:10.1159/000100428